IPO Watch, Feb. 3 -- Veeda Clinical Research has refiled its draft red herring prospectus (DRHP) with the capital market regulator, Securities and Exchange Board of India (SEBI), for an initial public offering (IPO).

The firm previously submitted its IPO documents to SEBI on September 27, 2021. Veeda Clinical Research was founded in 2004 and commenced operations in 2005 with its initial facility located in Ahmedabad, Gujarat, which was equipped to conduct Healthy Volunteer Studies (HVS).

The company provides a wide range of services that include both early and late-phase clinical trials, Healthy Volunteer Studies (HVS) that cover bioavailability and bioequivalence studies, pre-clinical trials, and non-clinical testing, along with biopha...